Valeria Runza

2.4k total citations
15 papers, 541 citations indexed

About

Valeria Runza is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Valeria Runza has authored 15 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Valeria Runza's work include Complement system in diseases (5 papers), Immune Cell Function and Interaction (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Valeria Runza is often cited by papers focused on Complement system in diseases (5 papers), Immune Cell Function and Interaction (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Valeria Runza collaborates with scholars based in Germany, United States and Switzerland. Valeria Runza's co-authors include Daniela N. Männel, Wilhelm Schwaeble, Carola H. Ries, Sabine Hoves, Michael A. Cannarile, Katharina Wartha, Solange Romagnoli, Michele De Palma, Wei Xu and Martina Schmittnaegel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Valeria Runza

15 papers receiving 535 citations

Peers

Countries citing papers authored by Valeria Runza

Since Specialization

Citations

This map shows the geographic impact of Valeria Runza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valeria Runza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valeria Runza more than expected).

Fields of papers citing papers by Valeria Runza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valeria Runza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valeria Runza. The network helps show where Valeria Runza may publish in the future.

Co-authorship network of co-authors of Valeria Runza

This figure shows the co-authorship network connecting the top 25 collaborators of Valeria Runza. A scholar is included among the top collaborators of Valeria Runza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valeria Runza. Valeria Runza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	End-to-end approach for the characterization and control of product-related impurities in T cell bispecific antibody preparations 2023 ·International Journal of Pharmaceutics X ·Laurent Larivière, (unknown), Thomas von Hirschheydt, Tilman Schlothauer, Katharine Bray‐French, Martin Bader, Valeria Runza	2
2	Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity 2018 ·The Journal of Experimental Medicine ·Sabine Hoves, Chia-Huey Ooi, (unknown), Hadassah Sade, Stefan Bissinger, Martina Schmittnaegel, Oliver Ast, Anna Maria Giusti, Katharina Wartha, Valeria Runza, Wei Xu, Yvonne Kienast, Michael A. Cannarile, Hyam I. Levitsky, Solange Romagnoli, Michele De Palma, Dominik Rüttinger, Carola H. Ries	153
3	A drug development perspective on targeting tumor‐associated myeloid cells 2017 ·FEBS Journal ·Meher Majety, Valeria Runza, Christian H.K. Lehmann, Sabine Hoves, Carola H. Ries	30
4	Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model 2016 ·PLoS ONE ·Daniela Maisel, Fabian Birzele, Edgar Voß, Adam Nopora, (unknown), Thomas Friess, Bernhard Göller, Daphna Laifenfeld, Stefan Weigand, Valeria Runza	15
5	Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia 2016 ·Oncotarget ·Norbert Vey, Jacques Delaunay, Giovanni Martinelli, Walter Fiedler, Emmanuel Raffoux, Thomas Prébet, Carlos Gomez‐Roca, Cristina Papayannidis, Maxim Kebenko, Peter Paschka, R D Christen, Ernesto Guarin, Ann-Marie E Bröske, Monika Baehner, Michael Brewster, Antje‐Christine Walz, Francesca Michielin, Valeria Runza, Valérie Méresse, Christian Récher	73
6	CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients 2015 ·Clinical Cancer Research ·Fabian Birzele, Edgar Voß, Adam Nopora, Konrad Honold, Florian Heil, (unknown), Henk M.W. Verheul, Christophe Le Tourneau, Jean‐Pierre Delord, Carla van Herpen, Devalingam Mahalingam, Andrew L. Coveler, Valérie Méresse, Stefan Weigand, Valeria Runza, Michael A. Cannarile	45
7	Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal 2015 ·Proceedings of the National Academy of Sciences ·Frida Holm, Eva Hellqvist, Cayla Mason, (unknown), Nathaniel P. Delos Santos, Christian Barrett, Hye-Jung E. Chun, Mark D. Minden, Richard A. Moore, Marco A. Marra, Valeria Runza, Kelly A. Frazer, Anil Sadarangani, Catriona Jamieson	37
8	Malignant Reprogramming of Progenitors into Leukemia Stem Cells Is Enhanced By Upregulation of CD44 Transcript Variant 3 in Malignant Microenvironments 2014 ·Blood ·Frida Holm, Eva Hellqvist, Cayla Mason, Christian Barrett, (unknown), Hye-Jung E. Chun, Marco A. Marra, Valeria Runza, Kelly A. Frazer, Anil Sadarangani, Catriona Jamieson	1
9	Abstract 4573: A novel bispecific Fap-Dr5 antibody inducing potent and tumor-specific death receptor 5 (Dr5) activation by fibroblast activation protein (Fap)-dependent crosslinking 2014 ·Cancer Research ·Katharina Wartha, Barbara Weiser, Thomas Friess, Meher Majety, Valeria Runza, Frank Herting, Thomas Weber, Werner Scheuer, (unknown), Hadassah Sade, Huifeng Niu, Peter Bruenker	1
10	Immature mouse granulocytic myeloid cells are characterized by production of ficolin-B 2013 ·Molecular Immunology ·(unknown), (unknown), (unknown), (unknown), Preetham Elumalai, Dominic Schmidt, Analía Trevani, Valeria Runza, Daniela N. Männel	14
11	CD44 Monoclonal Antibody-Enhanced Clearance Of Chronic Myeloid Leukemia Stem Cells From The Malignant Niche 2013 ·Blood ·Eva Hellqvist, Frida Holm, (unknown), Valeria Runza, Stefan Weigand, Anil Sadarangani, Catriona Jamieson	4
12	Functional analysis of mouse ficolin-B and detection in neutrophils 2012 ·Immunobiology ·(unknown), (unknown), Valeria Runza, Jens C. Jensenius, Daniela N. Männel	11
13	Ficolins: Novel pattern recognition molecules of the innate immune response 2007 ·Immunobiology ·Valeria Runza, Wilhelm Schwaeble, Daniela N. Männel	108
14	Localization of the mouse defense lectin ficolin B in lysosomes of activated macrophages 2006 ·Journal of Endotoxin Research ·Valeria Runza, Thomas Hehlgans, Bernd Echtenacher, Ulrich Zähringer, Wilhelm Schwaeble, Daniela N. Männel	30
15	Localization of the mouse defense lectin ficolin B in lysosomes of activated macrophages 2006 ·Journal of Endotoxin Research ·Valeria Runza, Thomas Hehlgans, Bernd Echtenacher, Ulrich Zähringer, Wilhelm Schwaeble, Daniela N. Männel	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact